1. Home
  2. PMM vs CINGW Comparison

PMM vs CINGW Comparison

Compare PMM & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMM
  • CINGW
  • Stock Information
  • Founded
  • PMM 1989
  • CINGW N/A
  • Country
  • PMM United States
  • CINGW United States
  • Employees
  • PMM N/A
  • CINGW 13
  • Industry
  • PMM Investment Managers
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMM Finance
  • CINGW Health Care
  • Exchange
  • PMM Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • PMM N/A
  • CINGW N/A
  • IPO Year
  • PMM N/A
  • CINGW 2021
  • Fundamental
  • Price
  • PMM $6.19
  • CINGW $0.05
  • Analyst Decision
  • PMM
  • CINGW
  • Analyst Count
  • PMM 0
  • CINGW 0
  • Target Price
  • PMM N/A
  • CINGW N/A
  • AVG Volume (30 Days)
  • PMM 118.3K
  • CINGW N/A
  • Earning Date
  • PMM 01-01-0001
  • CINGW N/A
  • Dividend Yield
  • PMM 4.68%
  • CINGW N/A
  • EPS Growth
  • PMM N/A
  • CINGW N/A
  • EPS
  • PMM 0.23
  • CINGW N/A
  • Revenue
  • PMM N/A
  • CINGW N/A
  • Revenue This Year
  • PMM N/A
  • CINGW N/A
  • Revenue Next Year
  • PMM N/A
  • CINGW N/A
  • P/E Ratio
  • PMM $26.52
  • CINGW N/A
  • Revenue Growth
  • PMM N/A
  • CINGW N/A
  • 52 Week Low
  • PMM $5.00
  • CINGW N/A
  • 52 Week High
  • PMM $6.42
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • PMM 48.11
  • CINGW N/A
  • Support Level
  • PMM $6.11
  • CINGW N/A
  • Resistance Level
  • PMM $6.24
  • CINGW N/A
  • Average True Range (ATR)
  • PMM 0.08
  • CINGW 0.00
  • MACD
  • PMM -0.01
  • CINGW 0.00
  • Stochastic Oscillator
  • PMM 26.47
  • CINGW 0.00

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: